As part of our commitment to expanding our presence in Poland, Cercare Medical is excited to participate in the upcoming Conference of the Vascular Diseases Section of the Polish Neurological Society – The Past and Future of Thrombolytic Treatment: 20 Years of Thrombolysis in Poland. The conference will take place on November 29-30, 2024, and will be held on-site.
As a leading innovator in Stroke solutions, we are thrilled to be part of this important event. It provides an opportunity to engage with top neurologists who share a common vision about the history and future of thrombolysis in Poland. We are deeply committed to supporting the advancement of medical technology in Poland and are proud to contribute to the ongoing progress in the field.
At Cercare Medical, we offer a suite of advanced, AI-driven imaging solutions designed for comprehensive stroke assessment, all integrated into the Cercare Medical Neurosuite. This fully automated system minimizes the need for manual intervention, streamlining the process and ensuring quicker, more accurate stroke assessments. Our goal is to make stroke care more efficient and accessible, that can help in improving outcomes for patients across Poland and beyond.
Visit our booth to experience live demonstrations of our cutting-edge perfusion imaging technologies. Discover how our software solutions enhance diagnostic precision and streamline clinical decision-making processes across a range of neurological conditions.
- Onsite Demo: Opportunity to engage with our technology and explore its real-world applications.
- Meet our Team: Our team will be available to discuss how Cercare Medical’s innovative solutions can be smoothly incorporated into your clinical workflows.
We look forward to being a part of this event, connecting with experts in the field, and continuing to provide solutions that play a pivotal role in the advancement of neurological care.
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and multi-vendor compatible software for CT and MRI perfusion imaging post-processing, we are committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.
